-+ 0.00%
-+ 0.00%
-+ 0.00%

Cardiff Oncology CEO Mani Mohindru acquires 34,364 shares worth $50,002.62

PUBT·07/16/2026 20:01:41
Listen to the news
Cardiff Oncology CEO Mani Mohindru acquires 34,364 shares worth $50,002.62
  • Cardiff Oncology CEO Mani Mohindru bought 34,364 common shares at $1.46, lifting direct holdings to 59,067 shares.
  • He also acquired 34,364 common stock purchase warrants with a $1.33 exercise price, holding 34,364 warrants.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-306072), on July 16, 2026, and is solely responsible for the information contained therein.